3D chromatin structure remodelling in cancer.
8 affiliations
- 1Department of Scientific Research and Teaching, Hunan Aerospace Hospital, Hunan Normal University, Changsha, Hunan, 410205, China.
- 2The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University, Changsha, Hunan, 410078, China.
- 3School of Basic Medical Sciences, Hunan Normal University Health Science Center, Hunan Normal University, Changsha, Hunan, 410013, China.
- 4Department of Scientific Research and Teaching, Hunan Aerospace Hospital, Hunan Normal University, Changsha, Hunan, 410205, China. [email protected].
- 5The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University, Changsha, Hunan, 410078, China. [email protected].
- 6FuRong Laboratory, Changsha, Hunan, 410078, China. [email protected].
- 7School of Basic Medical Sciences, Hunan Normal University Health Science Center, Hunan Normal University, Changsha, Hunan, 410013, China. [email protected].
- 8Xiangya School of Public Health, Central South University, Changsha, Hunan, 410013, China. [email protected].
Abstract
Three-dimensional (3D) chromatin structure is crucial for gene regulation and cellular identity, with alterations in this structure being closely associated with tumor development. Although the research of tumor genomics has made significant progress in the past decade, the mechanism of 3D chromatin structure in tumorigenesis is not completely clear. Recent studies have shown that the distortion of chromatin spatial conformation has become one of the core factors driving normal cell carcinogenesis by changing the gene regulatory network. Abnormal high-order chromatin organization leads to abnormal activation of oncogenes or silencing of tumor suppressor genes. This 3D chromatin disorder has been confirmed to be directly related to the phenotypic plasticity of a variety of tumors. Therefore, the dynamic changes of 3D chromatin structure play a key role in the occurrence and development of tumors, especially for malignant tumors with difficult diagnosis and lack of treatment. This article provides an overview of hierarchical alterations in cancer 3D chromatin structure, the mechanisms governing these changes, recent advances in detection technologies, and emerging therapeutic strategies. The unique 3D chromatin variation pattern in cancers may become a new biomarker and provide a theoretical basis for epigenetic therapy targeting chromatin spatial organization. In the future, integrating multi-omics data to develop specific drugs for key nodes of the 3D chromatin and establishing an early diagnosis system based on spatial chromatin characteristics will become an important direction to break through the bottleneck of cancer treatment.
Related
- Senescent Cell‐Derived Extracellular Vesicles in Therapy‐Induced Senescence: Immune Remodelling and Emerging Links to Mitochondrial Stress in Cancer
- Embryonic stem cells do not have a globally disrupted higher-order chromatin fiber structure
- Spatiotemporal transcriptomics for tumour microenvironment remodelling in cancer progression and therapy.
- Near-atomistic simulations reveal the molecular principles that control chromatin structure and phase separation
- Cellular, chromatin-accessibility, and spatial contextualization of bulk transcriptional patterns linked to positive peritoneal cytology in endometrial cancer
BibTeX
@article{liu2026chromatin,
title = {{3D chromatin structure remodelling in cancer.}},
author = {Yang Liu and Minghua Wu},
journal = {Cell communication and signaling : CCS},
year = {2026},
month = jul,
doi = {10.1186/s12964-026-03097-3},
url = {https://europepmc.org/article/MED/42907876},
note = {CC BY},
}
RIS
TY - JOUR
TI - 3D chromatin structure remodelling in cancer.
AU - Yang Liu
AU - Minghua Wu
PY - 2026
DA - 2026/07/01
JO - Cell communication and signaling : CCS
DO - 10.1186/s12964-026-03097-3
UR - https://europepmc.org/article/MED/42907876
AB - Three-dimensional (3D) chromatin structure is crucial for gene regulation and cellular identity, with alterations in this structure being closely associated with tumor development. Although the research of tumor genomics has made significant progress in the past decade, the mechanism of 3D chromatin structure in tumorigenesis is not completely clear. Recent studies have shown that the distortion of chromatin spatial conformation has become one of the core factors driving normal cell carcinogenesis by changing the gene regulatory network. Abnormal high-order chromatin organization leads to abnormal activation of oncogenes or silencing of tumor suppressor genes. This 3D chromatin disorder has been confirmed to be directly related to the phenotypic plasticity of a variety of tumors. Therefore, the dynamic changes of 3D chromatin structure play a key role in the occurrence and development of tumors, especially for malignant tumors with difficult diagnosis and lack of treatment. This article provides an overview of hierarchical alterations in cancer 3D chromatin structure, the mechanisms governing these changes, recent advances in detection technologies, and emerging therapeutic strategies. The unique 3D chromatin variation pattern in cancers may become a new biomarker and provide a theoretical basis for epigenetic therapy targeting chromatin spatial organization. In the future, integrating multi-omics data to develop specific drugs for key nodes of the 3D chromatin and establishing an early diagnosis system based on spatial chromatin characteristics will become an important direction to break through the bottleneck of cancer treatment.
SN - 1478-811X
ER -